Revenue in the pharmaceuticals market in Costa Rica 2028

The revenue in the pharmaceuticals market in Costa Rica was forecast to continuously increase between 2024 and 2028 by in total 109.8 million U.S. dollars (+27.81 percent). After the fifth consecutive increasing year, the indicator is estimated to reach 504.63 million U.S. dollars and therefore a new peak in 2028.

Find more key insights for the revenue in countries like Haiti, Chile, and Panama..

The Statista Market Insights cover a broad range of additional markets.

Revenue in the pharmaceuticals market in Costa Rica from 2017 to 2028 (in million U.S. dollars)

Characteristic	In million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

December 2023

More information

Region

Costa Rica

Survey time period

2017 to 2028

Supplementary notes

Data provided by Statista Market Insights are estimates.

The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi

Citation formats